Zobrazeno 1 - 10
of 199
pro vyhledávání: '"L Menchén"'
Publikováno v:
Pharmaceutical Care España, Vol 18, Iss 5 (2016)
Paciente habitual de la farmacia que acude a retirar su medicación durante un episodio claro de crisis hipertensiva.HTA
Externí odkaz:
https://doaj.org/article/3a40827bb11f4716a43c18169089ce87
Autor:
M Chaparro, D Acosta, C Rodríguez, F Mesonero, M Vicuña, M Barreiro-de Acosta, A Fernández-Clotet, Á Hernández Martínez, M Arroyo, I Vera, A Ruiz-Cerulla, B Sicilia, M J Cabello Tapia, C Muñoz Villafranca, J Castro-Poceiro, J Martínez Cadilla, M Sierra-Ausín, J M Vázquez Morón, E Montil Miguel, F Bermejo, V Royo, M Calafat, C González-Muñoza, E Leo Carnerero, N Manceñido Marcos, L Torrealba, H Alonso-Galán, J M Benítez, Y Ber Nieto, M T Diz-Lois Palomares, M J García, J F Muñoz, E M Armesto González, X Calvet, A Hernández-Camba, R E Madrigal Domínguez, L Menchén, J L Pérez Calle, M Piqueras, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 17:i806-i808
Background Main aim: To assess the durability of tofacitinib treatment in patients with ulcerative colitis (UC). Secondary aims: To assess the short and long-term effectiveness; the tolerability of tofacitinib in clinical practice; and to evaluate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::592845492cf6ce9454ce40638b4aaa99
https://doi.org/10.1093/ecco-jcc/jjac190.0805
https://doi.org/10.1093/ecco-jcc/jjac190.0805
Autor:
C Rubín De Célix, J Martín de Carpi, G Pujol, L Palomino, M Velasco, R Martín-Masot, V M Navas-López, E Ricart, M J Casanova, A Rodríguez Martínez, E Leo, A Alcaraz, M Mañosa, V Hernández, R Fernández, C Sánchez, L Menchén, F Mesonero, M Barreiro-De Acosta, N Martinon, C Tejido Sandoval, A Rendo Vázquez, P Corsino, R Vicente, A Hernández-Camba, J R Alberto Alonso, I Alonso-Abreu, A M Castro Millán, L Peries Reverter, B Castro, E Fernández-Salgado, M M Busto Cuiñas, J M Benítez, L Madero, F Clemente, S Riestra, S Jiménez-Treviño, M Boscá, M Chaparro, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 17:i37-i39
Background It has been suggested that the transition of patients from paediatric to adult care units may be key in the outcomes of inflammatory bowel disease (IBD). However, the impact of transition in real clinical practice has been barely studied.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e5b5cdf6fe59db8a2da918c9b10143c
https://doi.org/10.1093/ecco-jcc/jjac190.0027
https://doi.org/10.1093/ecco-jcc/jjac190.0027
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Y Gonzalez Lama, E Ricart, D Carpio, G Bastida, D Ceballos, D Ginard, I Marín-Jimenéz, L Menchén, F Muñoz
Publikováno v:
Journal of Crohn's and Colitis. 17:i782-i783
Background Over the last years significant advances have arisen in CD. New therapies with different mechanisms of action have been approved for the management of Crohn’s disease (CD). However, there is limited evidence on optimal positioning of age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70c2f18e34bf38a85daa9afa0acc0f29
https://doi.org/10.1093/ecco-jcc/jjac190.0784
https://doi.org/10.1093/ecco-jcc/jjac190.0784
Autor:
J Llaó, E Martín-Arranz, Y Zabana, M Navarro-Llavat, E Garcia-Planella, D Busquets, D Monfort, J R Pineda, A Gutiérrez, A Villoria, L Menchén, G Bastida, F J García-Alonso, M Rivero, M Chaparro, S Riestra, O Merino, I Rodríguez-Lago, M Barreiro-de-Acosta, E Domènech Moral
Publikováno v:
Journal of Crohn's and Colitis. 17:i755-i756
Background Oral corticosteroids remain as the first-line treatment for moderately active ulcerative colitis (UC). In controlled studies, they achieved clinical remission in 30-60% of patients at 30 days. In severe systemic diseases, intravenous bolus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79cbabe3bc1593cc8d9d204931d2e261
https://doi.org/10.1093/ecco-jcc/jjac190.0755
https://doi.org/10.1093/ecco-jcc/jjac190.0755
Autor:
Ofelia Baniandrés-Rodríguez, Paloma García-Piqueras, E. Hernández de la Torre-Ruiz, I. Balaguer-Franch, C. Lacasta-Plasin, L. Menchén-Viso
Publikováno v:
Clinical and Experimental Dermatology. 47:453-455
We present seven new cases of patients with Crohn disease who developed lesions clinically compatible with amicrobial pustulosis of the flexures during their treatment with anti-tumour necrosis factor therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00e860f890b4f061f5b2fd6222e9cfe7
https://doi.org/10.1111/ced.14909
https://doi.org/10.1111/ced.14909
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 99, Iss 11, Pp 648-652 (2007)
La enfermedad celiaca (EC) es una causa importante de elevación de transaminasas: entre un 5 y un 10% de los pacientes con elevación crónica, criptogénica, de las transaminasas presentan EC y, al contrario, la EC puede estar asociada a diferentes
Externí odkaz:
https://doaj.org/article/738e723e9fea4f19946d8ea1a0831dd9
Autor:
L. Menchén, C. Ripoll, I. Bretón, C. Moreno, C. de la Cuerda, M. Camblor, P. García-Peris, V. González-Lara, E. Cos
Publikováno v:
Nutrición Hospitalaria, Vol 20, Iss 1, Pp 26-37 (2005)
La enfermedad inflamatoria intestinal es una entidad crónica de etiología desconocida en cuyo desarrollo influyen múltiples variables, como son la susceptibilidad individual, genética e inmunológica, así como diferentes factores ambientales. Su
Externí odkaz:
https://doaj.org/article/a66118c0a06c483f88caa0cc4f7c156a
Autor:
M. Romero, L. Menchén
Publikováno v:
Nutrición Hospitalaria, Vol 28, Iss suppl 1, Pp 46-48 (2013)
Externí odkaz:
https://doaj.org/article/84a921e71a8c42538940267581b37a8f